Apollomics CEO Keeps Major Stake, Signals Long‑Term Growth & Strong Oncology Pipeline
Apollomics insider filing shows CEO’s steady stake and RSU vesting, signaling long‑term commitment to its oncology pipeline and potential upside from future milestones.
4 minutes to read